Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
51 studies found for:    Pamidronate
Show Display Options
Rank Status Study
1 Unknown  A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain
Condition: Low Back Pain
Intervention: Drug: pamidronate
2 Completed Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
Condition: Bone Disease, Metabolic
Interventions: Drug: Disodium pamidronate;   Drug: Placebo
3 Completed A Pilot Trial of IV Pamidronate for Low Back Pain
Condition: Chronic Low Back Pain
Intervention: Drug: Pamidronate
4 Completed
Has Results
Pamidronate to Treat Osteogenesis Imperfecta in Children
Condition: Osteogenesis Imperfecta
Intervention: Drug: Pamidronate (Aredia)
5 Withdrawn Study of Pamidronate for the Prevention of Heterotopic Ossification
Condition: Heterotopic Ossification
Intervention: Drug: Pamidronate (AREDIA)
6 Completed Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
Condition: Spondyloarthropathy
Interventions: Drug: golimumab;   Drug: Pamidronate
7 Not yet recruiting Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression
Condition: Ankylosing Spondylitis
Interventions: Drug: Pamidronate;   Other: Placebo (NaCl 0.9%)
8 Completed Pamidronate Administration in Breast Cancer Patients With Bone Metastases
Conditions: Breast Cancer;   Neoplasm Metastasis
Intervention: Drug: Pamidronate
9 Completed Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
Conditions: Refractory Multiple Myeloma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: pamidronate disodium;   Drug: arsenic trioxide;   Other: laboratory biomarker analysis;   Other: pharmacological study
10 Completed Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Condition: Multiple Myeloma
Interventions: Drug: Pamidronate;   Drug: Thalidomide
11 Completed The Use of Bisphosphonates in the Treatment of Avascular Necrosis of the Femoral Head
Condition: Femoral Head Avascular Necrosis
Intervention: Drug: Pamidronate Disodium
12 Completed
Has Results
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Condition: Multiple Myeloma
Interventions: Drug: Pamidronate;   Drug: Thalidomide;   Drug: Zometa
13 Completed The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Pamidronate;   Drug: Zoledronic acid;   Drug: placebo
14 Completed Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
Condition: Transplant Bone Disease
Interventions: Drug: Pamidronate;   Drug: vitamin D;   Drug: calcium supplement
15 Withdrawn Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
Conditions: Solid Tumor;   Metastatic Bone Disease
Interventions: Biological: denosumab;   Drug: pamidronate
16 Completed A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
Condition: Bone Loss
Intervention: Drug: Pamidronate
17 Unknown  Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty
Conditions: Arthroplasty;   Mineral Density
Intervention: Drug: pamidronate
18 Completed Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
Conditions: Osteopenia;   Complications of Heart-lung Transplant;   Other Complications of Lung Transplant
Intervention: Drug: zoledronic acid vs pamidronate
19 Unknown  Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease
Conditions: Intervertebral Disc Degeneration;   Modic I Discopathy;   Back Pain;   Low Back Pain;   Magnetic Resonance Imaging (MRI)
Interventions: Drug: Pamidronate;   Other: Placebo
20 Completed Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month
Condition: Multiple Myeloma
Intervention: Drug: pamidronate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.